Skip to main content
Erschienen in: BMC Gastroenterology 1/2020

Open Access 01.12.2020 | Research article

Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy

verfasst von: Tomoyuki Abe, Hironobu Amano, Tsuyoshi Kobayashi, Keiji Hanada, Minoru Hattori, Masahiro Nakahara, Hideki Ohdan, Toshio Noriyuki

Erschienen in: BMC Gastroenterology | Ausgabe 1/2020

Abstract

Background

Postoperative pancreatic fistula (POPF) is a life-threatening postoperative complication. The aim of this study was to evaluate the efficacy of the fistula risk score (FRS) and preoperative body composition factors for predicting the occurrence of clinically relevant POPF (CR-POPF) after pancreaticoduodenectomy (PD).

Methods

In this study, 136 consecutive patients who underwent PD between 2006 and 2018 were enrolled. The risk factors of CR-POPF (grades B and C) were analyzed. Preoperative visceral adipose tissue area (VATA), skeletal mass index (SMI), and subcutaneous adipose tissue area (SATA) were calculated from computed tomography data.

Results

The overall 30-day mortality and morbidity rates were 0.7 and 38%, respectively. The incidence rates of grade B and C CR-POPF were 27 and 4%, respectively. A univariate analysis revealed that male sex, habitual smoking, prognostic nutritional index (PNI) < 45, VATA ≥90, VATA/SATA ≥0.9, VATA/SMI ≥ 1.4, and FRS > 4 were significantly associated with the incidence of CR-POPF. A multivariate analysis revealed that PNI < 45, VATA/SMI ≥ 1.4 and FRS > 4 were the independent risk factors of CR-POPF.

Conclusions

Preoperative anthropomorphic imbalance, PNI, and FRS were independent risk factors for CR-POPF. Patients with high-risk factors should be closely monitored during the postoperative period.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12876-020-01397-7.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
Alb
Albumin
Amy
Amylase
BMI
Body mass index
CI
Confidence interval
CR-POPF
Clinically relevant postoperative pancreatic fistula
Cr
Creatinine
CRP
C-reactive protein
FRS
Fistula risk score
HU
Hounsfield unit
ISGPF
the International Study Group on Pancreatic Fistula
PD
Pancreaticoduodenectomy
POD
Postoperative day
POPF
Postoperative pancreatic fistula
PNI
Prognostic nutritional index
ROC
Receiver-operating characteristic
SATA
Subcutaneous adipose tissue area
SMI
Skeletal muscle index
T-Bil
Total bilirubin
VATA
Visceral adipose tissue area
WBC
White blood cells

Background

Regardless of surgical technique and perioperative management after patients undergo pancreatic resection, the postoperative complication rate remains high at 20 to 50% [13]. Among the postoperative complications, severe POPF remains of utmost concern as it can result in massive bleeding. Various risk factors of postoperative pancreatic fistula (POPF) have been identified, including a narrow main pancreatic duct, soft pancreatic texture, perioperative blood transfusion, high body mass index (BMI), and sarcopenia [48]. Callery et al. reported that a simple 10-point Fistula Risk Score (FRS) evaluated during pancreaticoduodenectomy (PD) and calculated on the basis of gland texture, pathology, pancreatic duct diameter, and intraoperative blood loss, accurately predicts POPF [9].
In 2016, the International Study Group on Pancreatic Fistula (ISGPF) redefined POPF [10] and recognized its prevalence at 13–30% [1, 4, 5]. Sarcopenia is defined as having a skeletal mass 2 standard deviations lower than the mean for healthy young adults [11, 12]. Skeletal mass is calculated using computed tomography (CT) data. Sarcopenia affects muscle function and is strongly associated with both short-term outcomes and long-term prognosis [7, 11]. Recent studies reported that an abundant visceral adipose tissue area (VATA) and a high ratio of VATA to skeletal muscle was associated with postoperative complications [13, 14]. Increased adipose tissue and sarcopenia deteriorate the host’s immune system, increasing their susceptibility to postoperative complications such as POPF [7, 8]. The aim of this study was to determine the efficacy of using the approach to predicting potential risk factors of CR-POPF from preoperative CT using PNI and FRS scores.

Methods

Patients

A total of 136 patients who underwent PD between 2006 and 2018 at the Department of Surgery, Onomichi General Hospital, were enrolled in this study. Patients who received palliative surgery were excluded from the study. Clinical and pathological data and preoperative CT findings were collected. Patients with pancreatic ductal adenocarcinoma, adenocarcinoma of the papilla, extrahepatic cholangiocarcinoma, intraductal papillary-mucinous carcinoma, and chronic pancreatitis were considered eligible. The study was approved by the local institutional review board (OJH-201642), and written informed consent was obtained from all the patients.

Preoperative CT analysis of body composition

Eight weeks prior to surgery, all the patients underwent a preoperative evaluation using non-enhanced and enhanced multi-detector CT (Discovery CT 750 HD, GE Healthcare, Milwaukee, WI, and Sensation 16, Siemens, Forchheim, Germany, respectively), with a section thickness of 2.5–5 mm. The CT slices at the third lumbar vertebra (L3) level were analyzed using Advantage Workshop 4.5 (GE Healthcare) and Virtual Place Fujin (AZE Ltd., Tokyo, Japan). The body composition assessment included calculations of the visceral adipose tissue area (VATA), subcutaneous adipose tissue area (SATA), and skeletal muscle area. CT analysis was performed by trained investigators who were blinded to the patients’ characteristics and clinical outcomes (HY, MY). The tissue Hounsfield unit (HU) thresholds were as follows: − 29 to 150 HU for the skeletal muscle area, − 190 to − 30 for the SATA, and − 150 to − 50 for the VATA. Skeletal muscle area was defined at the L3 level and included the psoas major and minor, paraspinal muscles (i.e., erector spinae and quadratus lumborum), and abdominal wall muscles (i.e., transversus abdominus, external and internal obliques, and rectus abdominis). The skeletal muscle area was normalized for height in meters squared (m2) to obtain the skeletal muscle index (SMI). The VATA/SMI ratio was defined as high if ≥1.4 and low if < 1.4 (Fig. 1). The cutoff value was estimated using a receiver-operating characteristic (ROC) curve analysis.

Definition of sarcopenia and pancreatic fistula

Sarcopenia was defined as follows: in men, a SMI of < 43 cm2/m2 with a BMI of < 25 kg/m2 or a SMI of < 53 cm2/m2 with a BMI of 25 kg/m2; and in women, a SMI of < 41 cm2/m2 [13]. Pancreatic fistula was defined in accordance with the current ISGPF criteria [10], and only fistulas of grades B and C were considered.

Surgical procedure and postoperative care

Surgery type was selected on the basis of tumor location. Subtotal stomach-preserving PD was routinely performed in the patients. Lymph nodes near the anterior and posterior surfaces of the pancreatic head were resected en bloc, and nodes of the superior mesenteric artery were resected en bloc when technically possible. The pancreatic stump was sutured using two-layer sutures end to end with the invagination of the jejunum. End-to-side hepaticojejunostomy was performed 5 cm distal to the pancreaticojejunostomy followed by side-to-side gastrojejunostomy. A round drain was positioned near the pancreatic anastomosis; and a flat drain, near the biliary anastomosis. Epidurals and non-steroid anti-inflammatory agents were routinely used during the procedure.
The patients with CR-POPF received total parenteral nutrition and octreotide (Sandostatin by Novartis, Rueil Malmaison, France), and a percutaneous drain was inserted under radiological guidance when the collection of infected fluid was suspected on CT.

Statistical analysis

Continuous variables were reported as medians and analyzed using the nonparametric Mann-Whitney U test. Categorical variables were compared using the Fisher exact test. Logistic regression was used to model categorical outcomes. Variables that showed statistically significant associations in the univariate analysis were entered into a multivariate logistic regression model. Differences between the results of the comparative tests were considered significant if a two-sided p value of < 0.05 was obtained. An FRS of > 4 was defined as high on the basis of the ROC curve analysis (Table 1). ROC curve analysis was applied to determine the cutoff values for the variables including PNI, VATA, SATA, SMI VATA/SMI, and VATA/SATA, which were determined to be independent risk factors. All the statistical analyses were performed using SPSS version 22 (IBM Corp., Armonk, NY).
Table 1
Fistula risk score for the prediction of clinically relevant pancreatic fistula after pancreatoduodenectomy
Risk factor
Parameter
Pointsa
Gland texture
Firm
0
Soft
2
Pathology
Pancreatic adenocarcinoma of pancreatitis
0
Ampullary, duodenal, cystic, and islet cell
1
Pancreatic duct diameter, mm
≥5
0
4
1
3
2
2
3
≤1
4
Intraoperative blood loss, mL
≤400
0
401–700
1
701–1000
2
> 1000
3
aTotal 0 to 10 points

Results

Patient characteristics

The median age of all the enrolled patients was 71 years (range, 35–86 years). Of the 136 patients enrolled, 94 were male and 42 were female. The overall 30-day mortality and morbidity rates were 0.7% (1/136 patients) and 38% (51/136 patients), respectively. The incidence rates of grade B and C POPF were 27.2% (37/136 patients) and 3.7% (5/136 patients), respectively. The most common pathological diagnosis was pancreatic tumor, followed by tumors in the papilla of Vater and extrahepatic bile duct. Preoperative sarcopenia was diagnosed in 53 patients (39%). The patients’ characteristics are shown in supplemental Table 1. The median VATA and SATA were 103.7 and 100.7 cm2/m2, respectively. The median score for FRS calculation was 4 (range, 0–9).

Risk factors of POPF

In the univariate analysis of the risk factors of POPF after pancreatectomy, male sex, habitual smoking, PNI < 45, VATA ≥90, VATA/SATA ≥0.9, VATA/SMI ≥ 1.4, and FRS > 4 were identified to be significantly associated with POPF (Table 2). The multivariate analysis results indicated that PNI < 45, VATA/SMI ≥ 1.4 and FRS > 4 score were independent risk factors of POPF.
Table 2
Univariate and multivariate analyses of risk factors of postoperative pancreatic fistula after pancreatectomy
Variable
Univariate analysis
 
Multivariate analysis
   
 
Non-POPF (n = 94)
POPF (n = 42)
p Value
Hazard ratio
95% CI
p Value
Age ≥ 75 years
35 (37%)
12 (29%)
0.339
   
Male
60 (64%)
34 (81%)
0.048
1.195
0.286–4.990
0.807
BMI ≥ 25 kg/m2
14 (15%)
11 (26%)
0.150
   
Diabetes mellitus
22 (23%)
5 (12%)
0.163
   
Habitual smoking
43 (45%)
28 (67%)
0.027
2.571
0.938–7.051
0.067
Habitual alcohol consumption
37 (39%)
22 (52%)
0.193
   
Preoperative biliary drainage
34 (36%)
12 (29%)
0.437
   
T-Bil ≥ 1 mg/dL
67 (71%)
28 (67%)
0.686
   
Alb ≥3.5 mg/dL
66 (70%)
34 (81%)
0.290
   
CRP ≥ 1 mg/dL
19 (20%)
9 (21%)
1.000
   
PNI < 45
51 (54%)
31 (74%)
0.037
2.659
1.045–6.767
0.040
Sarcopenia
40 (43%)
13 (31%)
0.254
   
VATA ≥ 90 cm2/m2
39 (41%)
32 (76%)
0.0002
   
SATA ≥88 cm2/m2
55 (59%)
28 (67%)
0.448
   
SMI < 42 cm2/m2
36 (38%)
10 (24%)
0.099
   
VATA/SATA ≥ 0.9
45 (48%)
32 (76%)
0.003
0.712
0.180–2.809
0.627
VATA/SMI ≥ 1.4
52 (55%)
39 (93%)
0.0004
14.712
3.06470.650
0.001
FRS high score (> 4 score)
36 (38%)
30 (71%)
0.006
4.820
1.96011.855
0.001
 Pancreatic adenocarcinoma or pancreatitis
45 (48%)
24 (57%)
0.357
   
Soft pancreatic texture
42 (45%)
30 (71%)
0.005
   
Pancreatic duct size < 3 mm
33 (35%)
28 (67%)
0.0011
   
 Estimated blood loss > 701 mL
47 (50%)
22 (52%)
0.849
   
Abbreviations: Alb albumin; Amy amylase; BMI body mass index; CI confidence interval; Cr creatinine; CRP C-reactive protein; POD postoperative day; POPF postoperative pancreatic fistula; PNI prognostic nutritional index; SATA subcutaneous adipose tissue area; SMI skeletal muscle index; T-Bil total bilirubin; VATA visceral adipose tissue area; WBC white blood cells
Variables in bold show statistically significant association (p < 0.05). All the variables are expressed as number (percentage)

Discussion

The results of our study demonstrate that high VATA/SMI, PNI < 45 and high FRS score were independent risk factors of POPF after PD. Patients with three risk factors were significantly more likely to have CR-POPF after PD. Previous reports that examined the relationship between sarcopenia and POPF focused only on skeletal muscle mass and visceral adipose tissue [8, 13, 15]. Sandini et al. reported that a high visceral adipose tissue-to-skeletal muscle ratio was a determinant of major postoperative complications after PD for malignancies [14]. Sui et al. reported that sarcopenia was not related to POPF, and patients with non-sarcopenia were strongly associated with POPF [16]. Another report showed that sarcopenia was an independent risk factor of POPF [7]. BMI, which is mainly a reflection of obesity, has been consistently reported as a risk factor of POPF [4]. Considering these reports, a close evaluation of body composition along with evaluations of BMI and sarcopenia could be effective for predicting POPF. Therefore, our VATA/SMI metric may be useful for a more precise evaluation of visceral fatty tissue and skeletal muscle imbalance. Some observations in this present study require clarification with respect to our higher CR-POPF rate than previously reported. First, there was a relatively high rate of soft pancreas and narrow main pancreatic size < 3 mm. Twenty-seven patients (60%) among those with PDAC were diagnosed with the disease at less than the pTNM stage I. The early detection of pancreatic cancer is correlated with long-term survival; however, obstructive pancreatitis caused by tumor progression did not occur in these patients. This could have increased the CR-POPF, even in patients with PDAC. Second, in the reconstruction, the pancreatic stump was sutured using two-layer sutures end to end with the invagination. Due to the relatively high rate of POPF, our reconstruction approach was recently changed to modified Blumgart anastomosis.
The underlying mechanism that links body composition and POPF still needs to be elucidated. Lutz et al. showed that the development of visceral adipose tissue is associated with an elevated production of proinflammatory molecules such as leptin, chemerin, resistin, tumor necrosis factor-α, interleukin (IL) 1, and IL-6 [17]. These proinflammatory cytokines suppress the host immune system and impede wound healing, thereby increasing susceptibility to infectious complications. Another line of thought suggests that in cancer patients, visceral adipose tissue may further disrupt certain catabolic pathways that promote the multimodal development of sarcopenia [18]. Sarcopenia itself may develop as a result of aging, catabolic disorders, cancer, and deficient nutrition, as well as impeded host immune activity through suppressed production of IL-15 [19]. Skeletal muscle tissue produces high levels of IL-15, which normally prevents muscle protein degradation and contributes to the regulation of adipose tissue formation and differentiation. The negative feedback induced by pro-cytokines likely plays a key role in the development of POPF after pancreatectomy.
From a surgical point of view, the presence of abundant visceral adipose tissue may interfere with anastomosis creation, which could result in increased intraoperative bleeding and operation time. Perioperative blood loss should be minimized to protect the patient’s immune system. In addition to high VATA, we determined other risk factors of POPF from pathological findings and postoperative clinical data.
The present multivariate analysis identified that the most effective predictor of CR-POPF was VATA/SMI. High BMI has a well-known association with obesity and surgical complications [20, 21]. Patients with a high proportion of body fat frequently have comorbidities such as diabetes mellitus, hypertension, and chronic heart failure. Obesity rates vary worldwide with low rates in Asia and high rates in America and Europe. Obesity status and BMI are both calculated using a weight-to-height ratio without a detailed consideration of body composition. In fact, the same BMI can be obtained with a large proportion of either total body adipose tissue or total muscle mass. Therefore, preoperative VATA and SMI assessments can provide reliable parameters for the prediction of POPF development and are advantageous because such evaluations could be applied worldwide.
Preoperative nutritional support and rehabilitation programs to decrease the risk of POPF are often implemented for patients with sarcopenia and poor nutritional status. Kaido et al. reported a positive impact of nutritional therapy on prognosis after living-donor liver transplantation especially in patients with sarcopenia [22]. However, multidisciplinary approaches will be required to prevent POPF in patients at high risk.
Several limitations of our study should be mentioned. First, this was a single-institution study, and the data were analyzed retrospectively. In addition, only Asian patients were included. Further studies are required to assess the feasibility of VATA/SMI, PNI, and FRS in predicting CR-POPF development.

Conclusions

In conclusion, our study demonstrates that preoperative body composition, defined by both visceral adipose tissue and skeletal muscle, are strong predictors of POPF incidence after pancreatectomy. Assessment of preoperative body composition is easy to perform, and reliable measurements can be obtained. Clinicians should closely monitor patients with a PNI < 45 and VATA/SMI ≥ 1.4.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12876-020-01397-7.

Acknowledgements

We thank the Center of Life Sciences at Hiroshima University for allowing the use of their facilities.

Availability data and materials

The datasets used and/or during current study are available from the corresponding author on reasonable request.
The study was approved by the local Institutional Review Board of Onomichi general hospital (OJH-201642), and written informed consent was obtained from all patients.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Kimura W, Miyata H, Gotoh M, et al. A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg. 2014;259:773–80.CrossRef Kimura W, Miyata H, Gotoh M, et al. A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg. 2014;259:773–80.CrossRef
2.
Zurück zum Zitat Simons JP, Shah SA, Ng SC, et al. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. 2009;13:1798–805.CrossRef Simons JP, Shah SA, Ng SC, et al. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. 2009;13:1798–805.CrossRef
3.
Zurück zum Zitat Sledzianowski JF, Duffas JP, Muscari F, et al. Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. Surgery. 2005;137:180–5.CrossRef Sledzianowski JF, Duffas JP, Muscari F, et al. Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. Surgery. 2005;137:180–5.CrossRef
4.
Zurück zum Zitat Aoki S, Miyata H, Konno H, et al. Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan. J Hepatobiliary Pancreat Sci. 2017;24:243–51.CrossRef Aoki S, Miyata H, Konno H, et al. Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan. J Hepatobiliary Pancreat Sci. 2017;24:243–51.CrossRef
5.
Zurück zum Zitat Fuks D, Piessen G, Huet E, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg. 2009;197:702–9.CrossRef Fuks D, Piessen G, Huet E, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg. 2009;197:702–9.CrossRef
6.
Zurück zum Zitat Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15–23.CrossRef Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15–23.CrossRef
7.
Zurück zum Zitat Nishida Y, Kato Y, Kudo M, et al. Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy. J Gastrointest Surg. 2016;20:1586–94.CrossRef Nishida Y, Kato Y, Kudo M, et al. Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy. J Gastrointest Surg. 2016;20:1586–94.CrossRef
8.
Zurück zum Zitat Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016;103:434–42.CrossRef Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016;103:434–42.CrossRef
9.
Zurück zum Zitat Callery M, Pratt W, Kent T, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216:1–14.CrossRef Callery M, Pratt W, Kent T, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216:1–14.CrossRef
10.
Zurück zum Zitat Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2016;138:8–13.CrossRef Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2016;138:8–13.CrossRef
11.
Zurück zum Zitat Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;12:1539–47.CrossRef Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;12:1539–47.CrossRef
12.
Zurück zum Zitat Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.CrossRef Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.CrossRef
13.
Zurück zum Zitat Sandini M, Bernasconi DP, Ippolito D, et al. Preoperative computed tomography to predict and stratify the risk of severe pancreatic fistula after pancreatoduodenectomy. Medicine (Baltimore). 2015;94:e1152.CrossRef Sandini M, Bernasconi DP, Ippolito D, et al. Preoperative computed tomography to predict and stratify the risk of severe pancreatic fistula after pancreatoduodenectomy. Medicine (Baltimore). 2015;94:e1152.CrossRef
14.
Zurück zum Zitat Sandini M, Bernasconi DP, Fior D, et al. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition. 2016;32:1231–7.CrossRef Sandini M, Bernasconi DP, Fior D, et al. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition. 2016;32:1231–7.CrossRef
15.
Zurück zum Zitat House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.CrossRef House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.CrossRef
16.
Zurück zum Zitat Sui K, Okabayshi T, Iwata J, et al. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy. Surg Today. 2018;48(5):545–51.CrossRef Sui K, Okabayshi T, Iwata J, et al. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy. Surg Today. 2018;48(5):545–51.CrossRef
17.
Zurück zum Zitat Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4:535–46.CrossRef Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4:535–46.CrossRef
18.
Zurück zum Zitat Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100–6.CrossRef Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100–6.CrossRef
19.
Zurück zum Zitat Quinn LS. Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition. J Anim Sci. 2008;86:E75–83.CrossRef Quinn LS. Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition. J Anim Sci. 2008;86:E75–83.CrossRef
20.
Zurück zum Zitat Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032–5.CrossRef Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032–5.CrossRef
21.
Zurück zum Zitat McAuliffe JC, Parks K, Kumar P, et al. Computed tomography attenuation and patient characteristics as predictors of complications after pancreaticoduodenectomy. HPB (Oxford). 2013;15:709–15.CrossRef McAuliffe JC, Parks K, Kumar P, et al. Computed tomography attenuation and patient characteristics as predictors of complications after pancreaticoduodenectomy. HPB (Oxford). 2013;15:709–15.CrossRef
22.
Zurück zum Zitat Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRef Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRef
Metadaten
Titel
Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy
verfasst von
Tomoyuki Abe
Hironobu Amano
Tsuyoshi Kobayashi
Keiji Hanada
Minoru Hattori
Masahiro Nakahara
Hideki Ohdan
Toshio Noriyuki
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2020
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01397-7

Weitere Artikel der Ausgabe 1/2020

BMC Gastroenterology 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.